SynthesisBJOG : an international journal of obstetrics and gynaecology2017
Self-administration of injectable contraceptives: a systematic review.
Synthesis in BJOG : an international journal of obstetrics and gynaecology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Reproductive justice in the time of COVID-19: a systematic review of the indirect impacts of COVID-19 on sexual and reproductive health.Reproductive health · 2021Pooled it
- Self-administered subcutaneous medroxyprogesterone acetate for improving contraceptive outcomes: a systematic review and meta-analysis.BMC women's health · 2021Pooled it
- Self-administration of injectable contraception: a systematic review and meta-analysis.BMJ global health · 2019Pooled it
- Self-administration of injectable contraceptives: a systematic review.BJOG : an international journal of obstetrics and gynaecology · 2017Pooled it
- Validation of a measure of contraceptive self-injection self-efficacy in Uganda.BMC women's health · 2025Article
- Change in Contraceptive Use Within South Carolina Medicaid Following the Choose Well Contraceptive Access Initiative: Did COVID-19 Alter the Trends?Women's health reports (New Rochelle, N.Y.) · 2024Article
- Determinants of DMPA-SC self-care/self-injectable contraceptive uptake among modern contraceptive users in Burkina Faso: findings from the 2021 demographic and health survey.Frontiers in global women's health · 2024Article
- Insights from Client Experience with Injection Medroxyprogesterone Acetate (MPA) in India: Lessons from the Field.Journal of obstetrics and gynaecology of India · 2022Article
- Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.Contraception · 2019Article
- Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.Contraception · 2018Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
backgroundThe contraceptive injectable is a safe and effective method that is used worldwide. With the variety of injectable delivery systems, there is potential for administration by the woman herself. Self-administration of the contraceptive injectable is the subject of this systematic review.
objectivesTo assess how effective and safe the contraceptive injectable method is when women themselves perform/administer it, compared with when the usual healthcare providers administer it. SEARCH STRATEGY: We searched PubMed, Popline, Cochrane, CINAHL, and Embase for articles with subject headings or text words related to 'self-administration' and 'contraception'. SELECTION CRITERIA: Studies that compared the administration of the contraceptive injectable by the woman herself versus administration by the healthcare provider were included. Outcomes of interest were continuation rates, safety, and the women's overall satisfaction with the contraceptive provider and method. DATA COLLECTION AND ANALYSIS: We undertook data extraction, descriptive analysis, and assessment of risk of bias. MAIN
resultsThree studies met the inclusion criteria. The best available evidence shows that there may be little or no difference in continuation rates when women self-administer contraceptive injections (326 per 1000 women; 95% CI 192-554 per 1000 women) compared with administration by healthcare providers (304 per 1000 women). Safety was not estimable as no serious adverse events were reported in any of the studies. With regards to overall satisfaction towards the provider and the method, the effect of the intervention was uncertain. AUTHORS'
conclusionsFindings suggest that with appropriate information and training the provision of contraceptive injectables for the woman to self-administer at home can be an option in some contexts. TWEETABLE ABSTRACT: This review assessed the continuation rates and safety of self-administration of the contraceptive injection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.